Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series.
Armando StabileFrancesco BarlettaGiovanni MotterleFrancesco PellegrinoGabriele SorceElio MazzoneSimone ScuderiGiuseppe Ottone CirulliVito CucchiaraAntonio EspositoGiorgio GandagliaNicola FossatiFrancesco De CobelliFrancesco MontorsiR Jeffrey KarnesAlberto BrigantiPublished in: Prostate cancer and prostatic diseases (2021)
There is no significant benefit in terms of csPCa detection when an adequate SBx is performed in combination with IL-TBx in patients with multiple mpMRI lesions. In these men target biopsy of secondary lesions can be safely omitted.